Progesterone receptor expression is an independent prognostic variable in early breast cancer: a population-based study

Longer-Term Outcomes of Letrozole Versus Placebo After 5 Years of Tamoxifen in the NCIC CTG MA.17 Trial: Analyses Adjusting for Treatment Crossover

(2011) Huan Jin et al.   JOURNAL OF CLINICAL ONCOLOGY

Assessment of Ki67 in Breast Cancer: Recommendations from the International Ki67 in Breast Cancer Working Group

(2011) M. Dowsett et al.   JNCI-Journal of the National Cancer Institute

A Review of an Unfavorable Subset of Breast Cancer: Estrogen Receptor Positive Progesterone Receptor Negative

(2011) J. P. Thakkar et al.   ONCOLOGIST

Increased mortality in HER2 positive, oestrogen receptor positive invasive breast cancer: a population-based study

(2010) C A Purdie et al.   BRITISH JOURNAL OF CANCER

HER2 assessment on core biopsy specimens using monoclonal antibody CB11 accurately determines HER2 status in breast carcinoma

(2010) Colin A Purdie et al.   HISTOPATHOLOGY

Ki67 in breast cancer: prognostic and predictive potential

(2010) Rinat Yerushalmi et al.   LANCET ONCOLOGY

Progesterone receptor is a significant factor associated with clinical outcomes and effect of adjuvant tamoxifen therapy in breast cancer patients

(2009) Shuzhen Liu et al.   BREAST CANCER RESEARCH AND TREATMENT

Automated image analysis for high-throughput quantitative detection of ER and PR expression levels in large-scale clinical studies: The TEAM Trial Experience

(2009) Dana Faratian et al.   HISTOPATHOLOGY

Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast Cancer

(2009) Maggie C. U. Cheang et al.   JNCI-Journal of the National Cancer Institute

Calibration and discriminatory accuracy of prognosis calculation for breast cancer with the online Adjuvant! program: a hospital-based retrospective cohort study

(2009) Stella Mook et al.   LANCET ONCOLOGY

Tissue microarrays compared with whole sections and biochemical analyses. A subgroup analysis of DBCG 82 b&c.

(2008) M. Kyndi et al.   ACTA ONCOLOGICA

Molecular profiles of progesterone receptor loss in human breast tumors

(2008) Chad J. Creighton et al.   BREAST CANCER RESEARCH AND TREATMENT

Relationship Between Quantitative Estrogen and Progesterone Receptor Expression and Human Epidermal Growth Factor Receptor 2 (HER-2) Status With Recurrence in the Arimidex, Tamoxifen, Alone or in Combination Trial

(2008) Mitch Dowsett et al.   JOURNAL OF CLINICAL ONCOLOGY

Prognostic Significance of Nottingham Histologic Grade in Invasive Breast Carcinoma

(2008) Emad A. Rakha et al.   JOURNAL OF CLINICAL ONCOLOGY

HER2 testing in the UK: further update to recommendations

(2008) R A Walker et al.   JOURNAL OF CLINICAL PATHOLOGY